-+ 0.00%
-+ 0.00%
-+ 0.00%

SET adds new listed securities : CNBIO80's units to be traded on November 19, 2026

The Stock Exchange of Thailand·11/18/2026 10:00:09
语音播报
Listing Listing : Depositary Receipt (DR) DR type : Depositary Receipt Representing Interest from Underlying Foreign Securities DR Name : DR ON GLOBAL X CHINA BIOTECH ETF ISSUED BY KRUNG THAI BANK PUBLIC COMPANY LIMITED DR Symbol : CNBIO80 Secondary market : SET Listed date : 19-Nov-2026 Trading date : 19-Nov-2026 Trading session : Day Trading Session (8:00 - 16:30) SEC Issuing Limit (Unit) : 3,400,000,000 Conversion Ratio (DR : Underlying) : 110 : 1 Offering type : Direct listing Offering Price (Baht per Unit) : 2.69 Description : DR selling price is the price calculated by the issuer based on the market price of the underlying foreign security, converted using a reference rate and exchange rate, and including the applicable administrative expenses incurred in buying foreign securities. Details of underlying Underlying Type : Units of Foreign Collective Investment Scheme Underlying Symbol : 2820 Underlying Name : GLOBAL X CHINA BIOTECH ETF (2820) Underlying Issuer Name : Mirae Asset Global Investments (Hong Kong) Limited Underlying Exchange : The Stock Exchange of Hong Kong Limited (HKEX) Underlying Exchange (URL) : https://www.hkex.com.hk/Market-Data/Securitie s-Prices/Exchange-Traded-Products/Exchange-Tr aded-Products-Quote?sym=2820&sc_lang=en Underlying Description : The investment objective of Global X China Biotech ETF's (the "Fund") is to provide investment results that, before fees and expenses, closely correspond to the performance of the Solactive China Biotech Index ______________________________________________________________________